ALK/FAK/Pyk2 Inhibitor CT-707

Known as: CT 707, CT-707 
An orally available inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK), focal adhesion kinase (FAK) and proline-rich tyrosine… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2016-2018
01220162018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
CT-707, a mutant-selective inhibitor of an important cancer target, anaplastic lymphoma kinase (ALK), is designed to be a… (More)
Is this relevant?
2018
2018
Given that YAP signaling acts as a critical survival input for hypoxic cancer cells in hepatocellular carcinoma (HCC), disruption… (More)
Is this relevant?
2016
2016
Hepatocellular carcinoma is among the leading causes of cancer-related deaths worldwide, and the development of new treatment… (More)
Is this relevant?